Shanghai Haohai Biological Technology Co. Ltd (5HB) — Cash Flow-to-Debt Ratio
Shanghai Haohai Biological Technology Co. Ltd (5HB) has a Cash Flow-to-Debt Ratio of 0.12x as of June 2023, meaning its operating cash flow of €141.99 Million could theoretically repay 0% of its total liabilities (€1.16 Billion) in one year. Check 5HB cash reinvestment to operating cash ratio to assess the company's total reinvestment commitment from operating cash flow.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Shanghai Haohai Biological Technology Co. Ltd Cash Flow-to-Debt Ratio (2016–2024)
Historical debt coverage capacity for Shanghai Haohai Biological Technology Co. Ltd across 9 annual periods. Also explore Shanghai Haohai Biological Technology Co assets under control for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for Shanghai Haohai Biological Technology Co. Ltd (2016–2024)
Year-by-year debt coverage analysis for Shanghai Haohai Biological Technology Co. Ltd. For market capitalisation and broader financial context, see market cap of Shanghai Haohai Biological Technology Co.
| Year | CF-to-Debt Ratio | Operating CF (EUR) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | 0.54x | €648.57 Million | €1.20 Billion | ▼ -7.6% |
| 2023 | 0.58x | €634.45 Million | €1.09 Billion | ▲ +149.6% |
| 2022 | 0.23x | €231.30 Million | €990.02 Million | ▼ -39.2% |
| 2021 | 0.38x | €342.29 Million | €890.07 Million | ▼ -17.2% |
| 2020 | 0.46x | €262.07 Million | €564.46 Million | ▼ -33.7% |
| 2019 | 0.70x | €348.91 Million | €498.52 Million | ▲ +7.5% |
| 2018 | 0.65x | €391.28 Million | €600.90 Million | ▲ +34.5% |
| 2017 | 0.48x | €343.06 Million | €708.59 Million | ▲ +34.6% |
| 2016 | 0.36x | €254.49 Million | €707.55 Million | — |